Onxeo SA (Germany) Analysis

Onxeo Stock Analysis Notes

About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.48. Some equities with similar Price to Book (P/B) outperform the market in the long run. Onxeo SA recorded a loss per share of 0.11. The entity had not issued any dividends in recent years. Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. Onxeo SA was incorporated in 1997 and is headquartered in Paris, France. ONXEO S operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 29 people. For more info on Onxeo SA please contact MD MPH at 33 1 45 58 76 00 or go to https://www.onxeo.com.

Onxeo SA Investment Alerts

Onxeo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 37.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Onxeo SA's market, we take the total number of its shares issued and multiply it by Onxeo SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 3rd of March, Onxeo SA holds the Semi Deviation of 9.88, coefficient of variation of 17920.71, and Risk Adjusted Performance of 0.0135. Onxeo SA technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Onxeo SA maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk to decide if Onxeo SA is priced some-what accurately, providing market reflects its current price of 0.052 per share.

Onxeo SA Price Movement Analysis

Onxeo SA Outstanding Bonds

Onxeo SA Predictive Daily Indicators

Onxeo SA Forecast Models

Onxeo SA's time-series forecasting models are one of many Onxeo SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Onxeo SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Onxeo SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Onxeo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Onxeo SA. By using and applying Onxeo Stock analysis, traders can create a robust methodology for identifying Onxeo entry and exit points for their positions.

When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.